the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

SK Group chief ordered to pay $1b in divorce case, shares in SK Inc soar

SEOUL: A South Korean court ruled SK Group Chairman Chey Tae-won must pay more than $1 billion to his estranged wife as part of their planned divorce, sending shares in the group’s holding firm surging on speculation that he will have to purchase more stock to cement his control.

The Seoul High Court found Chey’s shares in holding company SK Inc should be counted as part of the couple’s joint property, overturning a 2022 ruling by a lower court for a much smaller amount.

Chey was ordered on Thursday to pay 1.38 trillion won ($1 billion) in cash and 2 billion won in alimony to Roh Soh-yeong, the daughter of former South Korean President Roh Tae-woo.

Chey’s lawyers said he will appeal.

Shares in SK Inc jumped 9% after the ruling, giving it a market value of some 2 trillion won.

Chey owns 17.7% of the SK Inc and controls SK Hynix , the world’s second-largest memory chip maker, and other SK affiliates through his stake in SK Inc.

Park Ju-gun, head of corporate analysis firm Leaders Index, said that since the court ruling did not stipulate that Chey split his stock holding with Roh, he thought the chances of increased purchases of SK Inc stock were low.

He also said that, assuming the ruling stands, he thought Chey would be unlikely to sell his shares to make the payment but would probably take out loans using his SK Inc stock as collateral.

SK Group is South Korea’s second-largest conglomerate in terms of assets after Samsung, according to the country’s Fair Trade Commission. ($1 = 1,378.59 won)

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings